GSK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Shareholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...
FiercePharma22h
PMCPA brings the buzzkill to LinkedIn celebration, laying into GSK over employee’s clicks
The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a ...
GSK seen as potential target for activist investors
Drugmaker GSK has been tapped as a potential target for activist investors, according to Bloomberg, which noted that shares had fallen roughly 19% since spinning off its consumer health business in ...
Should you turn to Europe and tuck into the Granola shares?
This can be found among the Granolas, a group of 11 European multinationals, selected by US bank Goldman Sachs, which is made ...
MAHA’s misguided war on pharma
The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.
Aerosol Delivery Devices Market Set To Surge To $46.73 Billion By 2027 At A 4.9% CAGR
Aerosol Delivery Devices Market Research Report In 2019, the aerosol delivery devices market is projected to reach $46.73 billion by 2027, ...
BioPharma Dive19h
Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...